Krensavage Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-117,755
Closed -$8.8M 12
2020
Q1
$8.8M Sell
117,755
-4,106
-3% -$284K 2.83% 9
2019
Q4
$7.92M Sell
121,861
-429,854
-78% -$28M 2.7% 11
2019
Q3
$35M Buy
551,715
+478
+0.1% +$31.2K 13.43% 4
2019
Q2
$37.2M Sell
551,237
-7,590
-1% -$499K 12.09% 6
2019
Q1
$36.3M Buy
558,827
+28,128
+5% +$1.87M 9.82% 6
2018
Q4
$33.2M Sell
530,699
-9,137
-2% -$639K 11.21% 5
2018
Q3
$41.7M Buy
539,836
+6,767
+1% +$511K 10.71% 5
2018
Q2
$37.8M Buy
533,069
+11,066
+2% +$781K 9.64% 5
2018
Q1
$39.4M Buy
522,003
+43,950
+9% +$3.49M 9.55% 5
2017
Q4
$34.2M Sell
478,053
-42,871
-8% -$3.26M 10.68% 4
2017
Q3
$42.2M Sell
520,924
-11,510
-2% -$880K 13.16% 2
2017
Q2
$37.7M Sell
532,434
-4,587
-0.9% -$305K 11.44% 3
2017
Q1
$36.5M Buy
537,021
+117,021
+28% +$8.23M 11.76% 2
2016
Q4
$30.1M Buy
+420,000
New +$31.2M 10.78% 3

Other funds holding GILD

Krensavage Asset Management's GILD Position: Q2 2020 in Review

Krensavage Asset Management sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 117,755 shares — an estimated $8.8M sold.

Krensavage Asset Management first reported a position in GILD in Q4 2016 and held it in 14 quarters. The position peaked at $42.2M in Q3 2017. 1,626 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

  • Krensavage Asset Management reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
  • Krensavage Asset Management sold 117,755 Gilead Sciences shares in Q2 2020, an estimated $8.8M.
  • Krensavage Asset Management first reported a position in Gilead Sciences in Q4 2016 and held it in 14 quarters.
  • Krensavage Asset Management's Gilead Sciences position peaked at $42.2M in Q3 2017.
  • 1,626 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Krensavage Asset Management's 13F filing for Q2 2020, filed 17 Aug 2020.